CARDIOVASCULAR SENSITIVITY CHANGES TO EICOSANOIDS IN RATS WITH EXPERIMENTALLY INDUCED DIABETES-MELLITUS

被引:7
作者
HODGSON, WC
SIKORSKI, BW
KING, RG
机构
[1] Department of Pharmacology, Monash University, Clayton, Victoria
来源
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY | 1992年 / 19卷 / 01期
关键词
ALDOSE REDUCTASE INHIBITORS; ALLOXAN; ARACHIDONIC ACID; DIABETES-MELLITUS; PROSTACYLIN; STREPTOZOTOCIN; THROMBOXANE;
D O I
10.1111/j.1440-1681.1992.tb00391.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This paper attempts to provide a short review of the evidence for: 1. Increased platelet production of thromboxane A2 and reduced vascular production of prostacyclin in the human and also animal models of diabetes. 2. Reduced depressor responsiveness to arachidonic acid of anaesthetized alloxan- and streptozotocin-induced diabetic rats. 3. Enhanced constrictor responsiveness to arachidonic acid in blood-perfused hindquarters of alloxan-induced diabetic rats. 4. Potentiation by the thromboxane A2-mimetic, U46619, of constrictor responses to 5-hydroxytryptamine in Krebs'-perfused hindquarters and kidneys of both control and alloxan-induced diabetic rats. 5. Alterations during diabetes in production of, and responsiveness to, eicosanoids may contribute to the cardiovascular changes which occur in this disease.
引用
收藏
页码:9 / 15
页数:7
相关论文
共 57 条
[21]   DECREASED VASCULAR PROSTACYCLIN IN EXPERIMENTAL DIABETES [J].
HARRISON, HE ;
REECE, AH ;
JOHNSON, M .
LIFE SCIENCES, 1978, 23 (04) :351-356
[22]   AUGMENTED POTENTIATION OF RENAL VASOCONSTRICTOR RESPONSES BY THROMBOXANE-A2 RECEPTOR STIMULATION IN THE ALLOXAN-DIABETIC RAT [J].
HODGSON, WC ;
KING, RG ;
BOURA, ALA .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1990, 42 (06) :423-427
[23]   CHANGES IN ARACHIDONIC-ACID METABOLITE PATTERNS IN ALLOXAN-INDUCED DIABETIC RATS [J].
HUI, SCG ;
OGLE, CW ;
WANG, Z ;
AN, Y ;
HU, YH .
PHARMACOLOGY, 1989, 39 (05) :291-298
[24]  
JOHNSON M, 1979, LANCET, V1, P325
[25]  
JUNOD A, 1967, P SOC EXP BIOL MED, V126, P201
[26]   INCREASED PLATELET THROMBOXANE-B2 PRODUCTION IN NEWBORN-INFANTS OF DIABETIC MOTHERS [J].
KAAPA, P ;
KNIP, M ;
VIINIKKA, L ;
YLIKORKALA, O .
PROSTAGLANDINS LEUKOTRIENES AND MEDICINE, 1986, 21 (03) :299-304
[27]   PROSTACYCLIN AND THROMBOXANE IN DIABETIC CHILDREN [J].
KAAR, ML ;
KAAPA, P ;
VIINIKKA, L ;
YLIKORKALA, O .
PROSTAGLANDINS LEUKOTRIENES AND MEDICINE, 1983, 11 (03) :339-344
[28]  
Kador P F, 1985, Diabet Med, V2, P187
[29]   ALTERATIONS OF THE PROSTACYCLIN-THROMBOXANE RATIO IN STREPTOZOTOCIN INDUCED DIABETIC RATS [J].
KARPEN, CW ;
PRITCHARD, KA ;
MEROLA, AJ ;
PANGANAMALA, RV .
PROSTAGLANDINS LEUKOTRIENES AND MEDICINE, 1982, 8 (02) :93-103
[30]   REEVALUATION OF CIRCULATING PROSTACYCLIN AND THROMBOXANE IN DIABETES [J].
KAZAMA, Y ;
KANEMARU, Y ;
NOGUCHI, T ;
ONAYA, T .
PROSTAGLANDINS LEUKOTRIENES AND MEDICINE, 1987, 26 (02) :115-122